SCHEMBL339771

SCHEMBL339771

CCCCCCCCCCCCCCCCCCCCCC(=O)NC(CC)C(C(=O)[O-])[N+](C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CPT2 P23786 1/20 0.51
CPT1A P50416 1/20 0.51
CPT1B Q92523 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
FAAH O00519 2/20 0.50
MAPK1 P28482 1/20 0.50
DNM1 Q05193 1/20 0.45
DEGS1 O15121 2/20 0.44
CETP P11597 2/20 0.43
THRB P10828 1/20 0.43
NOD1 Q9Y239 1/20 0.42
PLA2G2C Q5R387 1/20 0.42
HSP90AA1 P07900 1/20 0.42
UGCG Q16739 2/20 0.42
PLA2G4A P47712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL324318 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL1309707 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL1310123 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL1091491 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL1310358 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL340199 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL17763255 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL340605 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL118838 1.00 CPT2 (0.51) CPT2CPT1ACPT1BMEN1KMT2A
SCHEMBL17763242 0.98 CPT2 (0.49) CPT2CPT1ACPT1BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166978-A1 METHOD OF MAKING DETERGENT GRANULES THE PROCTER & GAMBLE COMPANY 2024-05-23 US claimed
WO-2024092723-A1 METHOD OF MAKING DETERGENT GRANULES THE PROCTER & GAMBLE COMPANY (US) 2024-05-10 WO claimed
US-20240011976-A1 ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE BECKMAN COULTER, INC. 2024-01-11 US claimed
US-11801211-B2 Hair treatment formulations and uses thereof Chembeau LLC (US) 2023-10-31 US claimed
EP-4244625-A1 ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE Beckman Coulter, Inc. (US) 2023-09-20 EP claimed
US-20230140697-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF Chembeau LLC 2023-05-04 US claimed
US-20230099154-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF Chembeau LLC 2023-03-30 US claimed
WO-2022104147-A1 ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE BECKMAN COULTER, INC. (US) 2022-05-19 WO claimed
WO-2020036432-A1 COSMETIC COMPOSITION FOR PREVENTING FINE DUST ADHESION 주식회사 코스메카코리아 2020-02-20 WO claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
EP-1045891-A4 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF GOLDSCHMIDT CHEMICAL CORP (US) 2003-01-22 EP claimed
US-20020064510-A1 Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds GOLDSCHMIDT CHEMICAL CORPORATION (US) 2002-05-30 US claimed
US-6376455-B1 FABRIC SOFTENER, QUATERNARY FATTY ACID AMINO ALCOHOL ESTERS OF METHYLETHANOLISOPROPANOLAMINE (MEIPA) WITH FATTY ACIDS IN THE RATIO OF FROM 1:1.5 TO 1:2 WITH USE OF MONOFUNCTIONAL ALCOHOLS OR BIFUNCTIONAL ALCOHOLS. GOLDSCHMIDT REWO GMBH & CO. KG (DE) 2002-04-23 US claimed
US-6329353-B1 Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds GOLDSCHMIDT CHEMICAL CORPORATION 2001-12-11 US claimed
US-6211139-B1 Polyester polyquaternary compounds, compositions containing them, and use thereof GOLDSCHMIDT CHEMICAL CORPORATION 2001-04-03 US claimed
EP-1076554-A1 CLEAR PERSONAL CARE FORMULATIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS AND OTHER NITROGEN-CONTAINING COMPOUNDS Goldschmidt Chemical Company (US) 2001-02-21 EP claimed
EP-1045891-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF Goldschmidt Chemical Corporation (US) 2000-10-25 EP claimed
WO-1999058106-A1 CLEAR PERSONAL CARE FORMULATIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS AND OTHER NITROGEN-CONTAINING COMPOUNDS GOLDSCHMIDT CHEMICAL COMPANY (US) 1999-11-18 WO claimed
WO-1999035120-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF WITCO CORPORATION (US) 1999-07-15 WO claimed
WO-1999035223-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF WITCO CORPORATION (US) 1999-07-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH CPT2 123/4885CPT1A 703/4885CPT1B 107/4885
US-11801211-B2 Hair treatment formulations and uses thereof FHIT, SUCLG1, TES CPT2 270/4885CPT1A 610/4885CPT1B 1004/4885
US-20230099154-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF FHIT, SUCLG1, TES CPT2 270/4885CPT1A 610/4885CPT1B 1004/4885
US-20020064510-A1 Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds POLR1C, NUP50, ARG1 CPT2 1992/4885CPT1A 1870/4885CPT1B 1554/4885
US-20230140697-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF FHIT, SUCLG1, TES CPT2 270/4885CPT1A 610/4885CPT1B 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.